Asking for a close friend who is research faculty at a medical institution:He's acquired a license to use a drug for novel applications, and works with a research lab that has shown some promising results on a few diseases (i.e. cancer)He's raising funds to run through clinical trials, but is somewhat in stealth mode.I know for general tech VC (software), investors rarely if ever NDA's to see Seed/Series A decks.How about for biotech/pharma?